The latest piece of evidence comes from Included Health, which found that its telehealth platform helped lower the blood pressure of patients with hypertension over a 12-month period during the pandemic. The peer-reviewed study was published in Mayo Clinic Proceedings.
It’s the first week of the new year, and the life sciences sector continued the IPO momentum of 2021 as Wall Street welcomed three new biotech companies. Here’s a look at the IPOs of Amylyx Pharmaceuticals, CinCor Pharma, and Vigil Neuroscience, which raised a combined $482 million to support work on drugs addressing neurodegenerative and cardiovascular disorders.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, implementation and reimbursement.
The company, which offers an AI platform that provides personalized health coaching for chronic disease patients, will use the new funds to invest in research and development and to expand its virtual integrations with health plans and employers.
Hello Heart raised $45 million from growth equity firm IVP. It plans to use the funds to build up its platform as it goes toe-to-toe with large competitors in chronic disease management.
Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
The expanded partnership increases the number of Highmark health plan members eligible for enrollment in Lark Health's AI-driven health coaching programs aimed at managing and preventing chronic diseases.
Startups are turning to voice data as they try to develop tools to detect a wide range of diseases. One startup, Vocalis Health, is working with Mayo Clinic to identify voice-based biomarkers for pulmonary hypertension.
DarioHealth, a digital health company focused on patients with diabetes and hypertension, rolled out behavioral health coaching for its users.
Covid-19 has taken a particularly heavy toll on people with chronic conditions. We must make it easier for people to stay healthy at home by providing them with the information, supplies, and support they need delivered when and where they need it.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
At Livongo, we have developed and rolled out a targeted coronavirus response effort to keep our Members healthy, informed, and supported through the duration of this pandemic.
The implant — designated a breakthrough device by the FDA — would treat patients with pulmonary arterial hypertension. The progressive disease leads to heart failure but is usually treated with medication.
Oschner will partner with mail-order health company Hims & Hers to screen patients for blood pressure or diabetes.
The PBM selected 15 programs to offer on its first digital health formulary, starting in January 2020.
The company, which will be listed on the Nasdaq exchange under the ticker symbol "LVGO," offers tech-enabled solutions that help to monitor and manage people with chronic conditions like diabetes, hypertension and behavioral health issues.